T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 5, 2013

NCT03023176 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Fluzone® standard IIV3
BIOLOGICAL: Fluzone® standard IIV3 Pediatric Dose

Sponsor

Stanford University

Collaborators

[object Object]